An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Winnie Chua(University of Birmingham), Larissa Fabritz(University of Birmingham), Paul Brady(University College Cork), František Neháj(Sandwell & West Birmingham Hospitals NHS Trust), Stefan Kääb(German Centre for Cardiovascular Research), Eduard Guasch(Centro de Investigación en Red en Enfermedades Cardiovasculares), Stef Zeemering(Maastricht University), Moritz F. Sinner(LMU Klinikum), Jasmeet S. Reyat(Cardiovascular Institute Hospital), Ulrich Schotten(Maastricht University), Paulus Kirchhof(Universität Hamburg), Laura C. Sommerfeld(Universität Hamburg), Lluı́s Mont(Hospital Clínic de Barcelona), Peter Kastner(Roche Pharma AG (Germany)), Barbara Casadei(John Radcliffe Hospital), Elton Dudink(Maastricht University), Victor Roth Cardoso(University of Birmingham), Georgios V. Gkoutos(University Hospitals Birmingham NHS Foundation Trust), Harry J.G.M. Crijns(University Medical Center), Yanish Purmah(University of Birmingham), Stéphane Hatem(Fondation pour l’innovation en Cadiométabolisme et Nutrition), Christoph Al-Taie(Universität Hamburg), André Ziegler(Roche (Switzerland))
Scientific Reports
October 5, 2023
Cited by 28


Related Papers